European stocks set to open higher as investors digest earnings season

European stocks set to open higher as investors digest earnings season


L’Oreal warns the EU-U.S. trade deal would be costly

L’Oreal missed second-quarter sales forecasts, posting a 2.4% increase, as growth in Europe slowed more than expected. 

The cosmetics group saw a small rebound in the U.S. and China, which helped to offset weakness in other regions.

However, the company said it will push for exemptions from U.S. tariffs, warning the EU-U.S. trade deal would be costly, according to Reuters.

— Domi Suskova

Siemens Healthineers beats top line expectations

Siemens Healthineers has topped revenue forecasts for the third quarter, posting 7.6% growth to 5.7 billion euros ($6.6 billion) year on year.

The German medical technology group raised the midpoints of its outlook, even as CEO Bernd Montag warned that geopolitical volatility remains high.

— Michael Considine

Santander reveals record net profit in the second quarter

Santander posted a record net profit in the second quarter, coming in at 3.4 billion euros ($3.9 billion) and topping expectations. The Spanish lender also unveiled a 1.7 billion euro share buyback program as it reiterated its full year outlook.

— Michael Considine

European stocks set to open higher as investors digest earnings season

Good morning from London.

There’s just under an hour and a half to go until stocks begin trading, with the futures tied to the Stoxx Europe 600 index pointing to a gain of 0.2% when stock markets open.

Regionally, the U.K.’s FTSE 100 and Germany’s DAX are expected to rise 0.2% as well. Meanwhile, France CAC 40 index is set to be nearly flat, according to FactSet data.

European companies including Santander, BASF, UBS, HSBC, Siemens Healthineers, Mercedes-Benz, L’Oreal and Kering have reported earnings.

Ganesh Rao



Source

Novo Nordisk and Eli Lilly tumble after Hims & Hers announce  copy of Wegovy pill
World

Novo Nordisk and Eli Lilly tumble after Hims & Hers announce $49 copy of Wegovy pill

Weight-loss drugmakers Eli Lilly and Novo Nordisk tumbled after telehealth company Hims & Hers announced Thursday it will offer a copy of the newly launched Wegovy pill for $49, far less than the $149 Novo sells the branded pill for. Copenhagen-listed shares of Novo dropped as much as 9% on the news, while Eli Lilly […]

Read More
Google parent Alphabet shares are down premarket after its earnings beat. Here’s what’s happening
World

Google parent Alphabet shares are down premarket after its earnings beat. Here’s what’s happening

Alphabet’s shares were down in premarket trading on Thursday after the company beat Wall Street’s expectations on earnings and revenue, with AI spending projected to increase hugely this year. The Google parent shed 4.9% in premarket as of 7:50 a.m. ET, after closing nearly 2% lower on Wednesday. After the bell, Alphabet reported fourth-quarter revenue […]

Read More
Bank of England holds rates for now — so when’s the next cut coming?
World

Bank of England holds rates for now — so when’s the next cut coming?

People walk along Bank Junction next to the Bank of England in the City of London, the capital’s financial district. Vuk Valcic | SOPA Images | Lightrocket | Getty Images The Bank of England kept interest rates on hold at 3.75% at its first meeting of 2026 on Thursday. The central bank’s nine-member Monetary Policy […]

Read More